celastrol has been researched along with Fatty Liver, Nonalcoholic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Fan, N; Rong, J; Shen, Y; Shum, HC; Song, Q; Wang, Y; Zhang, X; Zhao, J; Zhao, W | 1 |
Fan, N; Li, D; Luo, D; Rong, J; Sun, Y; Wang, Y; Zhang, H; Zhang, X; Zhao, C; Zhao, J; Zhao, W | 1 |
Cao, X; Fu, Y; Gong, T; Ouyang, H; Pan, Y; Zhang, Y; Zhang, Z | 1 |
Liu, YC; Qin, SC; Xue, JL; Zhang, Y | 1 |
Chen, LM; Han, LP; Li, CJ; Sun, B; Xie, Y | 1 |
Chang, Y; Fang, F; Gao, M; Geng, C; Li, M; Liu, X; Zhang, Y | 1 |
1 review(s) available for celastrol and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
[Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease].
Topics: Humans; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Pentacyclic Triterpenes | 2023 |
5 other study(ies) available for celastrol and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease.
Topics: Animals; Diet, High-Fat; Lipid Metabolism; Lipids; Liver; Mice; Mice, Inbred C57BL; Nanoparticles; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; RNA, Messenger | 2022 |
Covalent Inhibition of Pyruvate Kinase M2 Reprograms Metabolic and Inflammatory Pathways in Hepatic Macrophages against Non-alcoholic Fatty Liver Disease.
Topics: Animals; Anti-Inflammatory Agents; Cholesterol; Glucose Transporter Type 1; Lipids; Macrophages; Mice; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-akt; Pyruvate Kinase; TOR Serine-Threonine Kinases; Triterpenes | 2022 |
Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease.
Topics: Animals; Chondroitin Sulfates; Lipids; Micelles; Non-alcoholic Fatty Liver Disease; Rats | 2023 |
Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cells.
Topics: Animals; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; Inflammation; Non-alcoholic Fatty Liver Disease; Pentacyclic Triterpenes; Rats; Toll-Like Receptor 4; Triglycerides; Triterpenes | 2018 |
Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Hepatocytes; Insulin Resistance; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pentacyclic Triterpenes; Sirtuin 1; Triterpenes | 2017 |